Clofarabine for myelodysplastic syndromes

Author： Tiu Ramon V Traina Fabiola Sekeres Mikkael A

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.7, 2011-07, pp. : 1005-1014

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 9, 2008-10 ,pp. : 902-902

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Decitabine: In Myelodysplastic Syndromes

By McKeage Kate Croom Katherine F.

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 951-958

Adis International

Access to resources Recommend Favorite

Azacitidine: In Myelodysplastic Syndromes

By Siddiqui M. Asif A. Scott Lesley J.

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1781-1789

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of myelodysplastic syndromes

By Galili Naomi Raza Azra

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1889-1899

Informa Healthcare

Access to resources Recommend Favorite

Developmental Therapeutics for Myelodysplastic Syndromes

By Naing Aung Sokol Lubomir List Alan F.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 1, 2006-01 ,pp. : 78-82

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite